Are you worried about the Foreign Corrupt Practices Act (FCPA), but had your fill of the usual programs reciting the requirements of the statute and statistics about the number of cases brought?
Are you looking for advice about the latest issues from lawyers with first-hand experience in the trenches?
Please join us for a breakfast program where we will address your questions as well as topics, including:
- How companies should conduct investigations in China now that an investigator for GlaxoSmithKline is under arrest there
- Which entities qualify as instrumentalities of the Chinese government subject to the FCPA in light of recent developments in the case law (and which do not)
- What are the latest best practices in compliance policies that the Department of Justice (DOJ) and the Securities and Exchange Commission (SEC) expect to see